PEG-MGF: What Pegylated MGF Is and What the Evidence Shows
Also known as:
often mentioned with:
Anonymous user report. Not medical advice. Peptides discussed are not FDA-approved for the uses described. Editorial process →
Short answer
PEG-MGF is MGF (mechano growth factor), a short lab-made peptide copied from the tail of an IGF-1 variant, with polyethylene glycol (PEG) chains attached so it is broken down more slowly. It is sold online as a "research peptide" for muscle growth and recovery. As of October 24, 2026 we could not find a single published study, in people or animals, that tested PEG-MGF itself. FDA says it has no human exposure data for PEG-MGF by any route and flags possible immune reactions and impurity problems. It is banned in sport at all times. Peptide Confessions does not publish dosing, timing, injection or sourcing guidance. Last reviewed October 24, 2026.
What is PEG-MGF?
MGF is the nickname for IGF-1Ec, a version of the IGF-1 gene product that muscle makes after heavy loading or damage. The product sold as "MGF" is the last 24 amino acids of its E-domain, a fragment that has never been isolated as a natural product from the body (Matheny 2010 review). The full background and the cell and animal research are on the MGF peptide page.
Pegylation means chemically attaching PEG, a long water-loving polymer, to a protein or peptide. It makes the molecule bigger, so the kidneys clear it more slowly and enzymes reach it less easily, which lengthens its time in the blood (Gaballa 2024 review). The "PEG" in PEG-MGF refers to that step. How much PEG, where it is attached and how pure the result is are not standardised for products sold online.
Does pegylation make MGF work better?
Nobody has shown that. Pegylation works in approved medicines, but each pegylated drug has had to prove its own safety and effect. The closest real-world example is Roche's pegylated IGF-1 (RO5046013), a different molecule: in a first-in-human trial in 62 healthy volunteers, pegylation stretched its half-life to roughly 140 to 200 hours and it was well tolerated, with injection-site redness the most common side effect (Kletzl 2017). That trial says nothing about PEG-MGF. Adding PEG can also change how a peptide binds and enters cells, and for MGF the basic effect on muscle cells is already disputed: an independent 2014 study by two drug-company labs could not reproduce it (Fornaro 2014).
What the research actually covers
A PubMed search on October 24, 2026 for PEG-MGF, pegylated MGF and pegylated mechano growth factor returned no study that gave PEG-MGF to cells, animals or people. The research usually quoted for PEG-MGF is about other forms. Doses are left out on purpose.
| Study | What was tested | Relevance to PEG-MGF |
|---|---|---|
| Carpenter 2008 | MGF E-domain peptide in sheep after a heart attack | Less damaged heart muscle at 8 days. Plain MGF peptide, not pegylated, not muscle growth |
| Mavrommatis 2013 | Synthetic E-domain peptide in heart cells and mice after a heart attack | Preserved heart function at 2 weeks. Not pegylated |
| Doroudian 2014 | MGF peptide loaded into tiny PEG-based gel rods, in cell culture | Released MGF for 2 weeks in a dish. A PEG gel delivery device, not PEG-MGF |
| Fornaro 2014 | Synthetic MGF and a stabilised MGF on mouse and human muscle cells | No effect on muscle-cell growth or fusion; undercuts the core claim |
| Dominikowski 2026 | Clinical review of GH and IGF-1 axis peptides used without prescription | Lists PEG-MGF among IGF-1 analogues clinicians now meet, in the tier with no human studies |
Claimed benefits vs evidence
| Claim | What the evidence supports |
|---|---|
| Lasts longer than plain MGF | Plausible for a pegylated peptide, but never measured for PEG-MGF; no published pharmacokinetics |
| Builds muscle anywhere in the body | No study. The muscle-cell effect of MGF itself failed independent replication |
| Faster recovery from training or injury | No study of PEG-MGF; MGF evidence is limited to animal injury models |
| Protects the heart | Sheep and mouse studies used plain MGF peptide, never tested in people |
| Safe because MGF is natural | The sold fragment is not a known natural product, and PEG adds its own immune issues (below) |
Side effects and risks
- —Unknown human safety. FDA states it "has not identified any human exposure data" on products containing PEG-MGF by any route and "lacks important information regarding any safety issues" (FDA, content current April 22, 2026).
- —Immune reactions. FDA says PEG-MGF may pose a significant risk of immunogenicity, meaning the body may make antibodies against it.
- —Anti-PEG antibodies. Some people already carry antibodies to PEG without ever taking a pegylated drug, and others develop them on treatment. They can speed up clearance of the drug and trigger complement-activation allergic-type reactions; FDA guidance asks drug makers to screen for them in trials (Gaballa 2024).
- —What is in the vial. Anti-doping labs have found MGF-like products that were not what the label implied: a chemically modified (amidated) MGF analogue in black-market products (Esposito 2012), a variant called MGF R23H in confiscated vials (Cox 2017), and a "full-length MGF" that was really a modified IGF-1Ec protein (Thevis 2014). FDA also flags impurity and characterisation problems for PEG-MGF.
- —Growth signalling. MGF belongs to the IGF-1 system. Reviews describe cancer-related (mitogenic) concerns with IGF-1 analogues as biologically plausible but unproven; for PEG-MGF there is no data either way.
Legal and sport status
PEG-MGF is not approved as a medicine in the US, Canada or the EU. FDA lists it among bulk drug substances that may present significant safety risks in compounding (FDA list). The WADA 2026 Prohibited List bans mechano growth factors (MGFs) at all times under S2.3, and the anti-doping methods above were built partly to catch them. In Canada, Health Canada has warned that unauthorized injectable peptides sold online can cause serious harm; see are peptides legal in Canada.
PEG-MGF vs MGF and other IGF-1 products
| Compound | What it is | Human evidence |
|---|---|---|
| PEG-MGF | MGF fragment with PEG attached | None; no published study of any kind found |
| MGF | 24-amino-acid E-domain fragment of IGF-1Ec | None for muscle; animal and cell studies only |
| IGF-1 LR3 | Long-acting IGF-1 analogue | No approved human use |
| Pegylated IGF-1 (RO5046013) | Roche research molecule | One first-in-human safety trial (Kletzl 2017); not marketed |
| Mecasermin | Recombinant IGF-1 | Approved for severe primary IGF-1 deficiency in children |
What users report
No one has published a PEG-MGF or MGF confession on this site yet (checked across 866 live confessions on October 24, 2026), so there are no user patterns to summarise. Growth-peptide stories from other compounds are on peptides for muscle growth and the IGF-1 LR3 hub.
Anonymous PEG-MGF reports
No reports found.
No one has published a PEG-MGF report here yet. If you have used it, submit what happened.
Submit yoursCommunity Q&A
- What is PEG-MGF?
- Pegylated mechano growth factor: the synthetic MGF peptide with polyethylene glycol attached to slow its breakdown. It is not an approved medicine anywhere.
- What are the benefits of PEG-MGF?
- None have been shown. No published study has tested PEG-MGF in people or animals, and the muscle-cell effect of plain MGF failed independent replication in 2014.
- What is the difference between PEG-MGF and MGF?
- PEG-MGF has PEG chains attached so it should last longer in the body. Neither has controlled human trials, and FDA has no human exposure data for PEG-MGF.
- Is PEG-MGF safe?
- Its safety is unknown. FDA flags possible immune reactions and impurity problems, and some people carry antibodies to PEG itself. Not medical advice.
- Is PEG-MGF legal in Canada or the US?
- It is not approved in either country. FDA lists it among compounding substances that may pose significant safety risks, and Health Canada warns about unauthorized injectable peptides.
- Is PEG-MGF banned in sport?
- Yes. The WADA 2026 Prohibited List bans mechano growth factors at all times under S2.3.
- Does this page give dosing advice?
- No. Peptide Confessions does not publish dosing, timing, injection or sourcing guidance.
Anonymous first-hand reports plus sourced context — educational only, not medical advice. Editorial policy & corrections.